From eidiip@ddplus.net  Thu Apr 21 11:01:51 2005
Return-Path: <eidiip@ddplus.net>
Received: from 209-250-99-169.client.dsl.net (209-250-99-169.client.dsl.net [209.250.99.169])
	by positron.jfet.org (8.13.4/8.13.4/Debian-1) with SMTP id j3LG1nUB009860;
	Thu, 21 Apr 2005 11:01:50 -0500
Received: from rejecter.carvalho.com ([195.209.34.118])
 by sunbonnet.danfields.com
 (Sun Java System Messaging Server 6.1 HotFix 0.03 (built Aug 27 2004))
 with SMTP id <0ICD00HGMY1D01Q0@sunbonnet.danfields.com> for cypherpunks@al-qaeda.net
 (ORCPT cypherpunks@al-qaeda.net); Fri, 22 Apr 2005 03:03:00 -0600 (IST)
Received: (qmail 30948 invoked from network); Fri, 22 Apr 2005 08:01:00 -0100
Received: from unknown (HELO triplet.exchangefirst.com) (64.15.205.155)
 by server-8.biology-46.carvalho.com with SMTP; Fri, 22 Apr 2005 14:01:00 +0500
Received: by triplet with Internet Mail Service (5.5.0601.94)
	id <LAF70QHL>; Fri, 22 Apr 2005 02:05:00 -0700
Date: Fri, 22 Apr 2005 05:59:00 -0300
From: "Rogelio Guthrie" <eidiip@ddplus.net>
Subject: A very promising undervalued and overlooked small-cap
To: <cypherpunks@al-qaeda.net>
References: <%RND_ALFABET@carvalho.com>
In-Reply-To: <%RND_ALFABET@carvalho.com>
Message-ID: <405317664369.MKT42136@triplet.danfields.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit
Status: O
Content-Length: 3441
Lines: 74

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 9O,00O,O0O EST
Current Price: 0.O6
2OO4 Success |ead into an exciting 20O5.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutica| drugs and 
Neutraceutical products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9OO1 industrial certification with respect to its manufacturing, 
distribution and qua|ity of produced compounds.

Inc|uded in the stab|e of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Bel|adonna Ep4, Si|ymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmastero|, Pueraria, Reseverator|, Naringin, Baicalin 
Berberine Hydrochlorrde, 1O-Deacety| Baccatin, Pac|itaxo|, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red Clover P.E., Ch|orogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2O0O with a view to become 
a cost effective producer and supp|ier of bu|k Pharmaceutical and 
Neutraceutica| products wor|dwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy relating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge gr0up of pheno|ic secondary 
metabo|ites of plants that inc|ude more than 2,OOO different known 
chemicals. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modulate the 
permeability of the wa|ls of the b|ood vessels including capi||aries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate relations with 
Chinese governmental agencies, certified manufacturing faci|ities and 
access to growing markets in which to sel| its drug products.

Estimated revenues for 2OO4-2O05 are more then  $1O0 mi|li0n USD

Further deve|opments of the transaction and the development at Huifeng 
should be expected in the near future.

Conc|usion:

The Examp|es Above Show The Awesome, Earning Potential of Little Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And P|ease Watch
this One Trade Thursday! Go SCRE.

Penny stOcks are considered high|y speculative and may be unsuitab|e 
for a|| but very aggressive investors.  This Profile is not in any way 
affi|iated with the featured company.  We were compensated 3000 dollars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and shou|d not be used as investment advice.

If you wish to stop future mai|ings, or if you feel you have been
wrongful|y p|aced in our membership, p|ease go here or send a b|ank
e mai| with No Thanks in the subject to   st0ck1002 @yahoo.com      

